Grifols Paysign

Seeking Alpha: Paysign, Inc. Announces Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions

HENDERSON, Nev.--(BUSINESS WIRE)-- Paysign, Inc. (PAYS) (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and ...

grifols paysign 2

Paysign, Inc. Announces Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions

Seeking Alpha: Paysign Is A Leader In Fintech Healthcare Payments With Durable Profitable Growth

grifols paysign 4

Paysign is a promising microcap payment processing company with a projected 42% annualized return, potentially reaching $19/share by 2030 from $3.30/share today. The company excels in two primary ...

Paysign Is A Leader In Fintech Healthcare Payments With Durable Profitable Growth

Paysign, Inc. is a small healthcare-focused Fintech company excelling in the $500M Patient Affordability market, with 230% revenue growth in its Pharma segment over the past four quarters. Despite a ...

Morningstar: Paysign, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results; Patient Affordability Drives 40% Revenue Growth and Significant Margin Expansion

Paysign, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results; Patient Affordability Drives 40% Revenue Growth and Significant Margin Expansion

Business Wire: Paysign, Inc. Appoints Jose Garcia as Executive Vice President, Life Science Solutions

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management software platforms and ...

grifols paysign 11

Paysign, Inc. Appoints Jose Garcia as Executive Vice President, Life Science Solutions

HENDERSON, Nev.--(BUSINESS WIRE)-- Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability solutions, financial technology products, and integrated payment processing services, today ...